Literature DB >> 21970136

Optimum bolus dose of propofol for tracheal intubation during sevoflurane induction without neuromuscular blockade in children.

S H Kim1, J Y Hong, E H Suk, S M Jeong, P H Park.   

Abstract

The purpose of this study was to determine the optimum bolus dose of propofol required to provide excellent conditions for tracheal intubation following inhalational induction of anaesthesia using 5% sevoflurane without neuromuscular blockade. Twenty-eight children, aged three to seven years, requiring anaesthesia for short duration surgery were recruited. Two minutes after beginning the inhalational induction with 5% sevoflurane and 60% nitrous oxide, a predetermined dose of propofol was injected over 10 seconds. Propofol dose was determined using the Dixon's up-and-down method, starting from 3 mg/kg (0.5 mg/kg as a step size). Laryngoscopy was performed 50 seconds after propofol injection. The optimum dose of propofol required for excellent intubating conditions was 1.39 +/- 0.37 mg/kg in 50% of children during inhalation induction using 5% sevoflurane and 60% nitrous oxide in the absence of neuromuscular blocking agents. From probit analysis, the 95% effective dose of propofol was 2.33 mg/kg (95% confidence interval 1.78 to 6.21 mg/kg).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21970136     DOI: 10.1177/0310057X1103900540

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  3 in total

1.  Hemodynamic changes following the administration of propofol to facilitate endotracheal intubation during sevoflurane anesthesia.

Authors:  Elisabeth Dewhirst; Christopher Lancaster; Joseph D Tobias
Journal:  Int J Clin Exp Med       Date:  2012-11-18

2.  General Anesthesia Maintained with Sevoflurane versus Propofol in Pediatric Surgery Shorter Than 1 Hour: A Randomized Single-Blind Study.

Authors:  Guisheng Wu; Xia Xu; Guanghua Fu; Ping Zhang
Journal:  Med Sci Monit       Date:  2020-06-23

3.  Total intravenous anesthesia induced and maintained by a combination of remimazolam and remifentanil without a neuromuscular blocking agent: a prospective, observational pilot study.

Authors:  Insun Park; Mincheul Cho; Sun Woo Nam; Jung-Won Hwang; Sang-Hwan Do; Hyo-Seok Na
Journal:  BMC Anesthesiol       Date:  2022-07-26       Impact factor: 2.376

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.